55 The SURMOUNT Program includes four global phase 3, randomized, placebo-controlled clinical trials with tirzepatide administered subcutaneously once weekly in conjunction with lifestyle intervention.47, 48, 49 There was a substantial degree of weight reduction with 10 mg and 15 mg doses of 18.420.9% in persons with obesity or preobesity (without diabetes), with improvements in cardiometabolic risk factors (Table 2).47, 48, 49 Lower bodyweight reductions of 12.8% and 14.7% with 10 mg and 15 mg doses of tirzepatide, respectively, were observed in persons with preobesity or obesity and T2DM
Reach out to us right away, because were here to support you
IGF-1 monitoring every 3 to 6 months is standard practice for anyone on a GH secretagogue
Gestational DM: Index under Diabetes, gestational O24.4xx series
If you have accidentally left your vial out, our guide on how long compounded tirzepatide can be out of the fridge helps you assess viability, and what happens if tirzepatide gets warm explains the degradation mechanism
Packaging Format : 1 vial containing a total of 10 mg peptide, composed of 5 mg cagrilintide and 5 mg semaglutide as a lyophilized (freezedried) powder in a sealed researchuse vial